JSC «BIOKHIMIK» RECEIVED 2 BILLION RUBLES FOR THE PRODUCTION OF ANTI-CANCER DRUGS FROM IDF
The «Biokhimik» pharmaceutical plant in Saransk will be able to open three new production lines for the production of drugs for the treatment of oncological diseases thanks to a loan from the Industrial Development Fund (IDF) in the amount of 2 billion rubles. This is reported by the official website of the IDF.
- Saransk Pharmaceutical Plant «Biokhimik» approved a loan in the amount of 2 billion rubles under the program «Priority projects». The company will launch three new production lines for the production of drugs for the treatment of oncological diseases. There are 23 items in their line, including anticancer drugs for chemotherapy and immunosuppressants, the report says.
It is noted that the total budget of the project is 6.6 billion rubles. The total production capacity of oncology drugs will be 26 million packages per year in various forms. Also, within the framework of the project, the company will launch two new production lines for the production of drugs of anatomical and therapeutic groups. The production capacity of these two lines will be almost 62 million packages per year in various forms.
During the implementation of the project, 172 jobs will be created, of which 159 are highly productive.